• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

CareFusion warns customers about Alaris syringe pump alarm

December 4, 2017 By Sarah Faulkner

CareFusion logoCareFusion issued a warning to customers of its Alaris syringe drug pump system, cautioning them that pumps made before 2008 may display an error message that could stop the pump from working.

The company wrote that it has received a report from a customer that the device displayed a re-occurring internal malfunction error code, PL3, which stops the pump and alerts the user with a high-pitched alarm tone and a red light.

Any pump made before September 2008 could produce this error code, the company wrote.

CareFusion advised that customers immediately remove Alaris pumps displaying any internal malfunction error code, including the PL3 message, and send them for servicing.

This is the latest in a series of warnings issued to CareFusion regarding its Alaris pumps over the past few years.

In February, the U.K.’s Medicines & Healthcare Products Regulatory Agency issued a second warning for the Alaris pump after CareFusion discovered that pumps with broken springs in the plunger assembly could accidentally release a single dose of medication.

The watchdog group first warned Alaris customers in December 2016 that the pump could release a dose of medication if it was used with non-recommended syringes.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Hospital Care, Pharmaceuticals, Regulatory/Compliance Tagged With: CareFusion

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS